Patients with thyroid eye disease who used the minimally invasive insulin-like growth factor I blocking antibody, teprotumumab, experienced improvement in […]
(HealthDay)—Nationwide, about half of Medicare fee-for-service beneficiaries with diabetes had eye exams in 2017, according to research published in the […]